David Thomas
MBBS, PhD
Professor and Director, Garvan-Weizmann Centre for Cellular Genomics
👥Biography 个人简介
David Thomas is an internationally recognized leader in sarcoma genomics and personalized therapy, directing Australia's national sarcoma research program. His work on the molecular landscape of synovial sarcoma, including the SS18-SSX fusion and its epigenetic consequences, has informed the development of targeted therapies such as EZH2 inhibitors and NY-ESO-1-directed T cell therapies. He co-founded the International Sarcoma Kindred Study (ISKS) to identify inherited predisposition to sarcoma. His translational genomics approach has advanced precision oncology for rare sarcoma subtypes.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 David Thomas 的研究动态
Follow David Thomas's research updates
留下邮箱，当我们发布与 David Thomas（Garvan Institute of Medical Research）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment